Beigene Ltd
SSE:688235

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
SSE:688235
Watchlist
Price: 277.54 CNY -0.7%
Market Cap: 247.6B CNY

Wall Street
Price Targets

Price Targets Summary
Beigene Ltd

Wall Street analysts forecast Beigene Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beigene Ltd is 369.66 CNY with a low forecast of 323.2 CNY and a high forecast of 444.57 CNY.

Lowest
Price Target
323.2 CNY
16% Upside
Average
Price Target
369.66 CNY
33% Upside
Highest
Price Target
444.57 CNY
60% Upside
Beigene Ltd Competitors:
Price Targets
NIOX
Niox Group PLC
21% Upside
688382
InventisBio Co Ltd
78% Upside
PHARM
Pharming Group NV
38% Upside
KMDA
Kamada Ltd
121% Upside
LVTX
LAVA Therapeutics NV
20% Downside
CRVO
Diffusion Pharmaceuticals Inc
165% Upside
PBYI
Puma Biotechnology Inc
14% Downside
PGEN
Precigen Inc
147% Upside

Revenue
Forecast

Revenue Estimate
Beigene Ltd

For the last 5 years the compound annual growth rate for Beigene Ltd's revenue is 56%. The projected CAGR for the next 3 years is 25%.

56%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Beigene Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Beigene Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beigene Ltd's stock price target?
Price Target
369.66 CNY

According to Wall Street analysts, the average 1-year price target for Beigene Ltd is 369.66 CNY with a low forecast of 323.2 CNY and a high forecast of 444.57 CNY.

What is Beigene Ltd's Revenue forecast?
Projected CAGR
25%

For the last 5 years the compound annual growth rate for Beigene Ltd's revenue is 56%. The projected CAGR for the next 3 years is 25%.

Back to Top